Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8668306 | Journal of Clinical Lipidology | 2018 | 10 Pages |
Abstract
Our patient has severe xanthomatosis out of proportion with the genetic diagnosis or biochemical measurements. Her xanthomatosis did not improve by pharmacological therapy consisting of statins and evolocumab despite a 50% reduction in low-density lipoprotein cholesterol. It is likely that the patient presented here has a second genetic disorder that leads to extensive xanthomatosis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sumayah MD, Isabelle PhD, Kevin MD, Jacques MD,